Singular Genomics Systems, Inc. (OMIC)
USD 20.01
(0.0%)
USD 20.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 67.52 Million USD | 28.57% |
| 2022 | 52.52 Million USD | 430.3% |
| 2021 | 9.9 Million USD | 16.94% |
| 2020 | 8.46 Million USD | 252.88% |
| 2019 | 2.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 65.71 Million USD | -14.31% |
| 2024 Q2 | 6.35 Million USD | -16.68% |
| 2023 FY | 67.52 Million USD | 28.57% |
| 2023 Q3 | 69.29 Million USD | 36.45% |
| 2023 Q2 | 50.78 Million USD | -1.68% |
| 2023 Q4 | 67.52 Million USD | -2.56% |
| 2023 Q1 | 51.65 Million USD | -1.65% |
| 2022 Q3 | 53.34 Million USD | -1.9% |
| 2022 Q1 | 13.81 Million USD | 39.53% |
| 2022 FY | 52.52 Million USD | 430.3% |
| 2022 Q4 | 52.52 Million USD | -1.55% |
| 2022 Q2 | 54.38 Million USD | 293.52% |
| 2021 Q4 | 9.9 Million USD | 0.36% |
| 2021 Q3 | 9.86 Million USD | 62.25% |
| 2021 Q2 | 6.08 Million USD | -95.92% |
| 2021 FY | 9.9 Million USD | 16.94% |
| 2021 Q1 | 149.19 Million USD | 1661.6% |
| 2020 Q4 | 8.46 Million USD | 0.0% |
| 2020 FY | 8.46 Million USD | 252.88% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 2.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 10.272% |
| AngioDynamics, Inc. | 3.93 Million USD | -1614.242% |
| AtriCure, Inc. | 60.59 Million USD | -11.439% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | -11.728% |
| BioLife Solutions, Inc. | 18.31 Million USD | -268.762% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 97.325% |
| Daxor Corporation | 755.65 Thousand USD | -8835.777% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -1297.434% |
| Femasys Inc. | 4.25 Million USD | -1485.748% |
| GlucoTrack, Inc. | 196 Thousand USD | -34351.02% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -119.919% |
| Hologic, Inc. | 2.49 Billion USD | 97.296% |
| ICU Medical, Inc. | 1.57 Billion USD | 95.72% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 182.246% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -1748.492% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -306.184% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 92.254% |
| Microbot Medical Inc. | 40 Thousand USD | -168710.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -1470370.383% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 91.796% |
| Nephros, Inc. | 1.39 Million USD | -4757.842% |
| NovoCure Limited | 596.24 Million USD | 88.675% |
| NEXGEL, Inc. | 513 Thousand USD | -13062.573% |
| NEXGEL, Inc. | 513 Thousand USD | -13062.573% |
| OraSure Technologies, Inc. | 11.38 Million USD | -492.94% |
| Pro-Dex, Inc. | 7.53 Million USD | -796.019% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -735.073% |
| Predictive Oncology Inc. | 2.18 Million USD | -2984.726% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -3384.264% |
| QuidelOrtho Corporation | 2.27 Billion USD | 97.031% |
| Repligen Corporation | 510.14 Million USD | 86.764% |
| Sanara MedTech Inc. | 9.11 Million USD | -640.953% |
| STAAR Surgical Company | 31.46 Million USD | -114.587% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -22789.492% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 96.24% |
| Jin Medical International Ltd. | - USD | -Infinity% |